Cargando…

Identification of Potential Immune Checkpoint Inhibitor Targets in Gliomas via Bioinformatic Analyses

BACKGROUND: Glioma is a common tumor originating from the glial cells of the brain. Immune checkpoint inhibitors can potentially be used to treat gliomas, although no drug is currently approved. METHODS: The expression levels of the immune checkpoint genes in glioma and normal tissues, and their cor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Mengmeng, Li, Yong-an, Lu, Zhimin, Hou, Guoxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860561/ https://www.ncbi.nlm.nih.gov/pubmed/35198632 http://dx.doi.org/10.1155/2022/1734847

Ejemplares similares

Targeting immune checkpoints in malignant glioma
por: Zhang, Xuhao, et al.
Publicado: (2016)

Identification of potential therapeutic targets for gliomas by bioinformatics analysis
por: Ma, Ke, et al.
Publicado: (2017)

Immune Checkpoint Inhibitors in Human Glioma Microenvironment
por: Ghouzlani, Amina, et al.
Publicado: (2021)

T lymphocyte-targeted immune checkpoint modulation in glioma
por: Kelly, William James, et al.
Publicado: (2020)

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy
por: Li, Guan-Zhang, et al.
Publicado: (2019)

Correction: T lymphocyte-targeted immune checkpoint modulation in glioma
Publicado: (2020)

Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
por: Qi, Yangzhi, et al.
Publicado: (2020)

Identification of a potential gene target for osteoarthritis based on bioinformatics analyses
por: Duan, Zhi-xi, et al.
Publicado: (2020)

Integrated identification of key genes and pathways in Alzheimer’s disease via comprehensive bioinformatical analyses
por: Yan, Tingting, et al.
Publicado: (2019)

Targeting T-cell metabolism to boost immune checkpoint inhibitor therapy
por: Li, Haohao, et al.
Publicado: (2022)

Bioinformatics analyses of potential ACLF biological mechanisms and identification of immune-related hub genes and vital miRNAs
por: Liang, Jiajun, et al.
Publicado: (2022)

Screening and Identification of Key Biomarkers in Lower Grade Glioma via Bioinformatical Analysis
por: Guo, Fangzhou, et al.
Publicado: (2022)

Identification of hub genes and biological pathways in glioma via integrated bioinformatics analysis
por: Chen, Lulu, et al.
Publicado: (2022)

Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis
por: Dong, Shu, et al.
Publicado: (2019)

Bioinformatics analyses for the identification of tumor antigens and immune subtypes of gastric adenocarcinoma
por: Wei, Shuxun, et al.
Publicado: (2022)

Identification and prediction of immune checkpoint inhibitors-related pneumonitis by machine learning
por: Gong, Li, et al.
Publicado: (2023)

miR-138 exerts anti-glioma efficacy by targeting immune checkpoints
por: Wei, Jun, et al.
Publicado: (2013)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

The Potential Cardiotoxicity of Immune Checkpoint Inhibitors
por: Nardi Agmon, Inbar, et al.
Publicado: (2022)

Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma
por: Zhang, Sibin, et al.
Publicado: (2022)

MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment
por: Zhou, Huiling, et al.
Publicado: (2023)

Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses
por: Ye, Shengda, et al.
Publicado: (2022)

Immune checkpoint inhibitors
por: Hui, Enfu
Publicado: (2019)

Immune checkpoint inhibitors
por: Kroemer, Guido, et al.
Publicado: (2021)

The Identification of Key Genes and Pathways in Glioma by Bioinformatics Analysis
por: Liu, Mingfa, et al.
Publicado: (2017)

Expression and prognostic value of long non-coding RNA H19 in glioma via integrated bioinformatics analyses
por: Xiao, Yilei, et al.
Publicado: (2020)

TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments
por: Liao, Ping, et al.
Publicado: (2023)

Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis
por: Wu, Chiao-En, et al.
Publicado: (2020)

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
por: Dmello, Crismita, et al.
Publicado: (2023)

Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Rotman, Galit, et al.
Publicado: (2013)

Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Levy, Ofer, et al.
Publicado: (2014)

Identification of biomarkers of venous thromboembolism by bioinformatics analyses
por: Wang, Guiming, et al.
Publicado: (2018)

Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma
por: Zhang, Sibin, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials
por: Li, Bin, et al.
Publicado: (2023)

Pan‐cancer analyses reveal that increased Hedgehog activity correlates with tumor immunosuppression and resistance to immune checkpoint inhibitors
por: Jiang, Junjie, et al.
Publicado: (2021)

Hyperthermia Targeting the Tumor Microenvironment Facilitates Immune Checkpoint Inhibitors
por: Li, Zihui, et al.
Publicado: (2020)

Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma
por: Wirsching, Hans-Georg, et al.
Publicado: (2021)

Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors
por: Fatima, Zainab, et al.
Publicado: (2023)

Identification of an Immune-Related LncRNA Signature in Gastric Cancer to Predict Survival and Response to Immune Checkpoint Inhibitors
por: Ding, Zuoyou, et al.
Publicado: (2021)

Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma
por: Da, Zijian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7neqia93i17quaetil2fjpl1rc